Utilization of FibroScan in Clinical Practice

Liver (B Bacon, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Liver

Abstract

The evaluation of liver fibrosis is critical, particularly to rule out cirrhosis. Novel non-invasive tests such as transient ultrasound elastography are widely used to stage liver fibrosis as an alternative to liver biopsy, and this technology has recently been approved in the US. In this review, we discuss the performance characteristics of elastography for a variety of liver diseases and highlight practical appropriate suggestions for how to incorporate this technology into clinical practice.

Keywords

Liver fibrosis Cirrhosis Viral hepatitis Liver stiffness Ultrasound elastography 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Rockey DC, Caldwell SH, Goodman ZD, et al. Liver biopsy. Hepatology. 2009;49:1017–44.PubMedCrossRefGoogle Scholar
  2. 2.
    Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology. 2008;134(6):1670–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Sandrin L, Fourquet B, Hasquenoph JM, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29:1705–13.PubMedCrossRefGoogle Scholar
  4. 4.••
    Castera L, Foucher J, Bernard PH, et al. Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology. 2010;51:828–35. A high BMI and obesity are factors that are associated with inaccurate LSM measurements.PubMedGoogle Scholar
  5. 5.
    Foucher J, Castera L, Bernard PH, et al. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations. Eur J Gastroenterol Hepatol. 2006;18:411–2.PubMedCrossRefGoogle Scholar
  6. 6.
    de Lédinghen V, Vergniol J, Foucher J, et al. Feasibility of liver transient elastography with FibroScan using a new probe for obese patients. Liver Int. 2010;30:1043–8.PubMedCrossRefGoogle Scholar
  7. 7.
    Friedrich-Rust M, Hadji-Hosseini H, Kriener S, et al. Transient elastography with a new probe for obese patients for non-invasive staging of non-alcoholic steatohepatitis. Eur Radiol. 2010;20:2390–6.PubMedCrossRefGoogle Scholar
  8. 8.•
    Wong VW, Vergniol J, Wong GL, et al. Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver disease. Am J Gastroenterol. 2012;107:1862–71. The XL probe is an important tool for patients with obesity and high BMI for accurate LSM measurements.PubMedCrossRefGoogle Scholar
  9. 9.
    Pradhan F, Ladak F, Tracey J, et al. Feasibility and reliability of the FibroScan S2 (pediatric) probe compared with the M probe for liver stiffness measurement in small adults with chronic liver disease. Ann Hepatol. 2013;12:100–7.PubMedGoogle Scholar
  10. 10.
    Colli A, Pozzoni P, Berzuini A, et al. Decompensated chronic heart failure: increased liver stiffness measured by means of transient elastography. Radiology. 2010;3:872–8.CrossRefGoogle Scholar
  11. 11.
    Arena U, Vizzutti F, Corti G, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology. 2008;47:380–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Sagir A, Erhardt A, Schmitt M, et al. Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage. Hepatology. 2008;47:592–5.PubMedCrossRefGoogle Scholar
  13. 13.
    Millonig G, Reimann FM, Friedrich S, et al. Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis. Hepatology. 2008;48:1718–23.PubMedCrossRefGoogle Scholar
  14. 14.•
    Tapper EB, Cohen EB, Patel K, et al. Levels of alanine aminotransferase confound use of transient elastography to diagnose fibrosis in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol. 2012;10:932–7. Elevated liver tests in patients with early stage fibrosis may cause an increase in LSM measurements and should be considered as a variable that can falsely raise liver stiffness.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.••
    de Lédinghen V, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012;32:911–8. CAP with transient elastography is an accurate mode of measurement of liver steatosis and represents a novel additional benefit of the technology.PubMedCrossRefGoogle Scholar
  16. 16.
    European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;1:167–85.Google Scholar
  17. 17.
    Lai M, Hyatt BJ, Nasser I, et al. The clinical significance of persistently normal ALT in chronic hepatitis B infection. J Hepatol. 2007;47:760–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Cardoso AC, Carvalho-Filho RJ, Stern C, et al. Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int. 2012;32:612–21.PubMedCrossRefGoogle Scholar
  19. 19.
    Ziol M, Handra-Luca A, Kettaneh A, et al. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology. 2005;41:48–54.PubMedCrossRefGoogle Scholar
  20. 20.
    Gara N, Zhao X, Kleiner DE, et al. Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2013;11:303–8.PubMedCrossRefGoogle Scholar
  21. 21.
    Malik R, Lai M, Sadiq A, et al. Comparison of transient elastography, serum markers and clinical signs for the diagnosis of compensated cirrhosis. J Gastroenterol Hepatol. 2010;25:1562–8.PubMedCrossRefGoogle Scholar
  22. 22.
    Bonder A, Afdhal NH. Biopsy no more; changing the screening and diagnostic algorithm for hepatitis C. Clin Gastroenterol Hepatol. 2013;11:309–10.PubMedCrossRefGoogle Scholar
  23. 23.
    Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA. 2002;288:199–206.PubMedCrossRefGoogle Scholar
  24. 24.
    Graham CS, Baden LR, Yu E, et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis. 2001;33:562–9.PubMedCrossRefGoogle Scholar
  25. 25.
    Sánchez-Conde M, Montes-Ramírez ML, Miralles P, et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J Viral Hepat. 2010;17:280–6.PubMedCrossRefGoogle Scholar
  26. 26.
    Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology. 2006;43:1118–24.PubMedCrossRefGoogle Scholar
  27. 27.
    Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 2011;34:274–85.PubMedCrossRefGoogle Scholar
  28. 28.
    Arase Y, Suzuki F, Suzuki Y, et al. Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C. Hepatology. 2009;49:739–44.PubMedCrossRefGoogle Scholar
  29. 29.
    de Lédinghen V, Vergniol J, Foucher J, et al. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography. Liver Int. 2012;32:911–8.PubMedCrossRefGoogle Scholar
  30. 30.
    Alkhouri N, Sedki E, Alisi A, et al. Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. Liver Int. 2013;33:79–85.PubMedCrossRefGoogle Scholar
  31. 31.
    Bureau C, Metivier S, Peron JM, et al. Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease. Aliment Pharmacol Ther. 2008;27:1261–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Kazemi F, Kettaneh A, N’kontchou G, et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J Hepatol. 2006;45:230–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Pritchett S, Cardenas A, Manning D, et al. The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific. J Viral Hepat. 2011;18:e75–80.PubMedCrossRefGoogle Scholar
  34. 34.••
    Klibansky DA, Mehta SH, Curry M, et al. Transient elastography for predicting clinical outcomes in patients with chronic liver disease. J Viral Hepat. 2012;19:e184–93. Transient elastography is a good tool to stratify high-risk patients with chronic liver disease and can predict risk of liver decompensation.PubMedCrossRefGoogle Scholar
  35. 35.
    Cescon M, Colecchia A, Cucchetti A, et al. Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma. Ann Surg. 2012;256:706–12.PubMedCrossRefGoogle Scholar
  36. 36.
    Singh S, Fujii LL, Murad MH, et al. Liver Stiffness Measurements are Associated with Risk of Decompensation, Liver Cancer, and Death in Patients with Chronic Liver Diseases: a Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol. 2013;15:S1542–3565.Google Scholar
  37. 37.
    Becker L, Salameh W, Sferruzza A, et al. Validation of hepascore, compared with simple indices of fibrosis, in patients with chronic hepatitis C virus infection in United States. Clin Gastroenterol Hepatol. 2009;7:696–701.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Liver Center, Department of Medicine, Beth Israel Deaconess Medical CenterHarvard Medical SchoolBostonUSA

Personalised recommendations